Lung cancer continues to affects more individuals each passing year. According to a new study led by Curtin University, people with incurable forms of lung cancer may survive longer if they engage…
Year: 2023
Dizal Published New Pivotal Phase II Trial Data on Sunvozertinib in NSCLC
Shanghai-based biopharmaceutical company, Dizal, has published new Pivotal Phase II Trial Data on sunvozertinib in non-small cell lung cancer (NSCLC). Sunvozertinib is an oral and selective tyrosine kinase inhibitor that has a…
Research Suggests Allergy Medicine may Treat Lung Cancer
Icahn School of Medicine researchers have reported that they discovered an ingredient in allergy medicine that can reduce lung cancer tumors. In their study, they found that when blocked, an allergy pathway…
New Study Finds A Way To Stop Key Lung Cancer Spread Protein
Lung cancer is among the most common types of cancers prevailing all over the world. A new study by Tulane University has found a molecular pathway to stop lung cancer spread. The…
Durvalumab for Treatment of Lung Cancer
Durvalumab is a type of immunotherapy and is known by its brand name, Imfinzi. Its role in treatment of small cell lung cancer is increasing. Durvalumab injection is injected into a vein…
Lung Cancer Cell “Memories” Suggest New Strategy for Improving Treatment
A new understanding of lung cancer cells “memories” suggest a new strategy for improving lung cancer treatment, according to Memorial Sloan Kettering Cancer Center (MSK) researchers. In this research, they have found…
Lung Cancer Screening Improves Lung Cancer Survival Sharply
November is being celebrated as lung cancer month to aware people all around the world about this disease. Lung cancer remains the leading cause of cancer deaths in the United States and…
Lung Cancer Awareness Month November 2023: Theme and Importance
Since 1995, November is held as a global health event for Lung Cancer Awareness Month. The organization, all around the world, run campaigns and activities to edcuare people about lung cancer awareness….